Home›People›Denis Patrick
DP

Denis Patrick

Director at EvolveImmune Therapeutics Holding Company.

Director
Updated Nov 19, 2026·Latest SEC filing Nov 1, 2024·Suggest an edit

About Denis Patrick

Form D filings for EvolveImmune Therapeutics Holding Company from 2020 to 2024 list Denis Patrick as director.

Denis Patrick first appears on SEC filings in 2020.

Experience

This experience comes from SEC filings. The years are when the filings name Denis Patrick in the role, so the role may have started earlier or lasted longer.

EvolveImmune Therapeutics Holding Company, LLC
Director
2020 – 2024 · Branford, CT
Develops immune-based cancer treatments for patients with solid tumors and blood cancers.

Key Colleagues at Startups

The people Denis Patrick works with at each company, as listed on that company's latest Form D.

IT
Ian Taylor
Director
DY
Derek Yoon
Director
SB
Stephen Bloch
Co-founder and Chief Executive Officer, director

Sources

  1. SECEvolveImmune Therapeutics Holding Company, LLC Form D, filed Nov 1, 2024